Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT03395210
- 2019.282 PRINCIPIA BIOPHARMA - PRN1008-010 - CT1191
Trial sponsor
Principia Biopharma, a Sanofi Company
Scientific Title
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of PRN1008, an Oral BTK Inhibitor, in Patients With Relapsed Immune Thrombocytopenia